Research ArticleSpecial Contributions
The Applications of PET in Clinical Oncology
Ludwig G. Strauss and Peter S. Conti
Journal of Nuclear Medicine April 1991, 32 (4) 623-648;
Article Information
vol. 32 no. 4 623-648
PubMed
Published By
Print ISSN
Online ISSN
Copyright & Usage
COPYRIGHT © 1991 by The Society of Nuclear Medicine, Inc.
Author Information
Statistics from Altmetric.com
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
Article usage
In this issue
The Applications of PET in Clinical Oncology
Ludwig G. Strauss, Peter S. Conti
Journal of Nuclear Medicine Apr 1991, 32 (4) 623-648;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Spatially Resolved Measurement of Dynamic Glucose Uptake in Live Ex Vivo Tissues
- Estimation of Tumor Volumes by 11C-MeAIB and 18F-FDG PET in an Orthotopic Glioblastoma Rat Model
- Prognostic Value of Total Lesion Glycolysis by 18F-FDG PET/CT in Surgically Resected Stage IA Non-Small Cell Lung Cancer
- Preclinical Characterization of 5-Amino-4-Oxo-[6-11C]Hexanoic Acid as an Imaging Probe to Estimate Protoporphyrin IX Accumulation Induced by Exogenous Aminolevulinic Acid
- Glyceraldehyde-3-phosphate Dehydrogenase Is Activated by Lysine 254 Acetylation in Response to Glucose Signal
- Reply: Comment on: "Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET/CT"
- New Approach to Quantification of Molecularly Targeted Radiotracer Uptake from Hybrid Cardiac SPECT/CT: Methodology and Validation
- Correlation of 18F-FDG Uptake with Apparent Diffusion Coefficient Ratio Measured on Standard and High b Value Diffusion MRI in Head and Neck Cancer
- Simplified Quantification of Myocardial Flow Reserve with flurpiridaz F 18: Validation with Microspheres in a Pig Model
- Shortened Acquisition Protocols for the Quantitative Assessment of the 2-Tissue-Compartment Model Using Dynamic PET/CT 18F-FDG Studies
- Evaluation of Metabolic Characteristics and Viability of Lipiodolized Hepatocellular Carcinomas Using 18F-FDG PET/CT
- Impact of Dynamic 18F-FDG PET on the Early Prediction of Therapy Outcome in Patients with High-Risk Soft-Tissue Sarcomas After Neoadjuvant Chemotherapy: A Feasibility Study
- Modulation of Caspase-Independent Cell Death Leads to Resensitization of Imatinib Mesylate-Resistant Cells
- [18F]Fluorodeoxyglucose Positron Emission Tomography in Nonseminomatous Germ Cell Tumors After Chemotherapy: The German Multicenter Positron Emission Tomography Study Group
- Impact of Angiogenesis-Related Gene Expression on the Tracer Kinetics of 18F-FDG in Colorectal Tumors
- 68Ga-Labeled Bombesin Studies in Patients with Gastrointestinal Stromal Tumors: Comparison with 18F-FDG
- The Feasibility of 18F-FDG PET Scans 1 Month After Completing Radiotherapy of Squamous Cell Carcinoma of the Head and Neck
- Early Detection of Cancer Recurrence: 18F-FDG PET/CT Can Make a Difference in Diagnosis and Patient Care
- "Flying Through" and "Flying Around" a PET/CT Scan: Pilot Study and Development of 3D Integrated 18F-FDG PET/CT for Virtual Bronchoscopy and Colonoscopy
- Radionuclide Imaging for the Detection of Inflammation in Vulnerable Plaques
- Radionuclide imaging of the painful hip arthroplasty: POSITRON-EMISSION TOMOGRAPHY VERSUS TRIPLE-PHASE BONE SCANNING
- Molecular and Metabolic Imaging of Atherosclerosis
- Prognostic Aspects of 18F-FDG PET Kinetics in Patients with Metastatic Colorectal Carcinoma Receiving FOLFOX Chemotherapy
- 18F-FDG Kinetics and Gene Expression in Giant Cell Tumors
- In Vitro Proton Magnetic Resonance Spectroscopic Lactate and Choline Measurements, 18F-FDG Uptake, and Prognosis in Patients with Lung Adenocarcinoma
- Prognostic and Therapeutic Indicator of Fluoroboronophenylalanine Positron Emission Tomography in Patients with Gliomas
- Shortened PET Data Acquisition Protocol for the Quantification of 18F-FDG Kinetics
- Delayed 18F-FDG PET for Detection of Paraaortic Lymph Node Metastases in Cervical Cancer Patients
- PET in the follow-up of differentiated thyroid cancer
- Evaluation of 18F-FDG PET with Bladder Irrigation in Patients with Uterine and Ovarian Tumors
- Prospective Comparison of 18F-FDG PET with Conventional Imaging Modalities (MRI, CT, and 67Ga Scintigraphy) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma
- Usefulness of Whole-Body 18F-FDG PET in Patients with Suspected Metastatic Brain Tumors
- Whole-Body 18F-FDG PET Identifies High-Risk Myeloma
- Combined Functional and Structural Evaluation of Cancer Patients with a Hybrid Camera-Based PET/CT System Using 18F-FDG
- Role of 18F-FDG Dual-Head Gamma-Camera Coincidence Imaging in Recurrent or Metastatic Colorectal Carcinoma
- The Role of Quantitative 18F-FDG PET Studies for the Differentiation of Malignant and Benign Bone Lesions
- Relationship Between Retention Index in Dual-Phase 18F-FDG PET, and Hexokinase-II and Glucose Transporter-1 Expression in Pancreatic Cancer
- 11C-Acetate PET Imaging of Prostate Cancer
- Clinical Value of Iodine-123-Alpha-Methyl-L-Tyrosine Single-Photon Emission Tomography in the Differential Diagnosis of Recurrent Brain Tumor in Patients Pretreated for Glioma at Follow-Up
- Combined 18F-FDG and 11C-Methionine PET Scans in Patients with Newly Progressive Metastatic Prostate Cancer
- 18F-FDG PET Detection of Lymph Node Metastases in Medullary Thyroid Carcinoma
- FDG Uptake and Glucose Transporter Subtype Expressions in Experimental Tumor and Inflammation Models
- Clinical Impact of 18F-FDG PET in Thyroid Carcinoma Patients with Elevated Thyroglobulin Levels and Negative 131I Scanning Results After Therapy
- Dynamic PET 18F-FDG Studies in Patients with Primary and Recurrent Soft-Tissue Sarcomas: Impact on Diagnosis and Correlation with Grading
- Quantitative PET Studies in Pretreated Melanoma Patients: A Comparison of 6-[18F]Fluoro-L-Dopa with 18F-FDG and 15O-Water Using Compartment and Noncompartment Analysis
- Parametric Images of Blood Flow in Oncology PET Studies Using [15O]Water
- Treatment of SW620 Cells with Tomudex and Oxaliplatin Induces Changes in 2-Deoxy-D-Glucose Incorporation Associated with Modifications in Glucose Transport
- Positron Emission Tomography Using [18F]-Fluorodeoxy-D-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
- Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1
- A new way to look at inflammatory bowel disease
- Positron Emission Tomography for Evaluating Para-aortic Nodal Metastasis in Locally Advanced Cervical Cancer Before Surgical Staging: A Surgicopathologic Study
- Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose
- Positron Emission Tomography: Current Role for Diagnosis and Therapy Monitoring in Oncology